Olon Group to acquire GTP Bioways Group from Merieux Equity.

Olon Group, a global leader in the development and production of active pharmaceutical ingredients, agreed to acquire GTP Bioways Group, a French company operating as Biotech CDMO, from Merieux Equity, a private equity firm. Financial terms were not disclosed. "The acquisition of GTP Bioways Group implies a strong and significant strengthening of Olon’s service pipeline with the aim of creating new business opportunities, acquiring new customers and high-potential market areas, and ultimately continuing the company’s growth," Paolo Tubertini, Olon Group CEO.